SCHEMBL8524358

SCHEMBL8524358

Cc1ccccc1[C@H]1CO1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.52
TSHR P16473 2/20 0.46
HTR2C P28335 5/20 0.46
HTR2A P28223 3/20 0.46
HTR2B P41595 3/20 0.46
ALDH1A1 P00352 2/20 0.42
GLA P06280 1/20 0.42
ACHE P22303 1/20 0.41
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
HRH3 Q9Y5N1 2/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8525267 1.00 TAAR1 (0.52) TAAR1TSHRHTR2CHTR2AHTR2B
SCHEMBL168917 1.00 TAAR1 (0.52) TAAR1TSHRHTR2CHTR2AHTR2B
SCHEMBL30036880 1.00 TAAR1 (0.52) TAAR1TSHRHTR2CHTR2AHTR2B
SCHEMBL30370069 1.00 TAAR1 (0.52) TAAR1TSHRHTR2CHTR2AHTR2B
SCHEMBL28338939 0.86 TAAR1 (0.45) TAAR1TSHRHTR2CHTR2AHTR2B
SCHEMBL8889457 0.84 TAAR1 (0.44) TAAR1TSHRHTR2CHTR2AHTR2B
SCHEMBL10779356 0.82 HTR2C (0.49) TAAR1TSHRHTR2CHTR2AHTR2B
SCHEMBL37732 0.82 TSHR (0.57) TSHRHTR2ACHRM2CHRM4CHRM1
SCHEMBL27405786 0.77 HTR2C (0.43) TAAR1TSHRHTR2CHTR2AHTR2B
SCHEMBL7783854 0.76 HPGD (0.36) TAAR1TSHRHTR2CHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1757584-A1 Heterocyclic substituted amides, their production and their use Abbott GmbH & Co. KG (DE) 2007-02-28 EP disclosed
US-5872117-A TREATING CEREBROVASCULAR DEMENTIA, SENILE DEMENTIA, ALZHEIMER'S DEMENTIA, SEQUELAE OF ISCHEMIC ENCEPHALOPATHY AND CEREBRAL APOPLEXY TOYAMA CHEMICAL CO., LTD. (JP) 1999-02-16 US disclosed
EP-0587194-B1 2-(Heterocycloalkoxy)-1-(subst.-phenyl)-ethanol derivatives as cerebral function improving agents TOYAMA CHEMICAL CO LTD (JP) 1997-06-04 EP disclosed
EP-0587193-B1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO LTD (JP) 1997-01-02 EP disclosed
US-5472984-A 1,2-ethanediol derivative and salt thereof and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1995-12-05 US disclosed
EP-0589484-A1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-30 EP disclosed
EP-0587194-A1 2-(Heterocycloalkoxy)-1-(subst.-phenyl)-ethanol derivatives as cerebral function improving agents TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-16 EP disclosed
EP-0587193-A1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-16 EP disclosed
US-5280032-A 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-01-18 US disclosed
EP-0383281-A1 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1990-08-22 EP disclosed